Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-05-065114
Filing Date
2005-12-07
Accepted
2005-12-07 11:48:27
Documents
1
Period of Report
2005-12-07

Document Format Files

Seq Description Document Type Size
1 rrd99195.html 4  
1 rrd99195.xml 4 5021
  Complete submission text file 0001181431-05-065114.txt   6787
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 2078782770
BRIGHAM MICHAEL F (Reporting) CIK: 0001136544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 051248858